Clinical Trial Update: Screening for MASLD-related Advanced Fibrosis in Type 2 Diabetes [NA]

View source ↗

Summary

This clinical trial update notes a NOT_YET_RECRUITING study evaluating screening for MASLD-related advanced liver fibrosis in people with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Fibrosis
• Metabolic Dysfunction-associated Steatotic Liver Disease
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Steatotic Liver Disease, Fibrosis of Liver | NA | Status: NOT_YET_RECRUITING